(S)-4-amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile is claimed as a highly selective, PI3Kδ inhibitor. It is claimed to be useful in the treatment of asthma and appears intended for oral administration. It is shown to be well absorbed after oral administration and to have reasonable metabolic stability.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1517/13543776.2014.870155 | DOI Listing |
Publication Analysis
Top Keywords
pi3kδ inhibitor
8
treatment asthma
8
oral administration
8
evaluation wo2013116562a
4
wo2013116562a orally
4
orally active
4
active pi3kδ
4
inhibitor treatment
4
asthma s-4-amino-6-1-5-chloro-4-oxo-3-phenyl-34-dihydroquinazolin-2-ylethylaminopyrimidine-5-carbonitrile
4
s-4-amino-6-1-5-chloro-4-oxo-3-phenyl-34-dihydroquinazolin-2-ylethylaminopyrimidine-5-carbonitrile claimed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!